7,8-cyclopropataxanes
    2.
    发明授权
    7,8-cyclopropataxanes 失效
    7,8-环丙烷

    公开(公告)号:US5254580A

    公开(公告)日:1993-10-19

    申请号:US29819

    申请日:1993-03-11

    CPC分类号: C07D305/14

    摘要: An antitumor compound of formula I ##STR1## in which R.sup.1 is --COR.sup.z in which R.sup.z is t-butyloxy, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.3-6 cycloalkyl, or phenyl, optionally substituted with one to three same or different C.sub.1-6 alkyl, C.sub.1-6 alkoxy, halogen or --CF.sub.3 groups;R.sup.2 is C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.3-6 cycloalkyl, or a radical of the formula --W--R.sup.x in which W is a bond, C.sub.2-6 alkenediyl, or --(CH.sub.2).sub.t --, in which t is one to six; and R.sup.x is naphthyl, furyl, thienyl or phenyl, and furthermore R.sup.x can be optionally substituted with one to three same or different C.sub.1-6 alkyl, C.sub.1-6 alkoxy, halogen or --CF.sub.3 groups;R.sup.3 is OCOR, --OCOOR, H, or OH; R.sup.4 is hydrogen; or R.sup.3 and R.sup.4 jointly form a carbonyl group; and R is C.sub.1-6 alkyl.Also provided by this invention are pharmaceutical formulations (compositions) and a method of treating mammalian tumors with a compound of formula I.

    摘要翻译: 式I的抗肿瘤化合物,其中R 1为-COR z,其中R z为叔丁氧基,C 1-6烷基,C 2-6烯基,C 2-6炔基,C 3-6环烷基或苯基,任选被 一至三个相同或不同的C 1-6烷基,C 1-6烷氧基,卤素或-CF 3基团; R 2是C 1-6烷基,C 2-6烯基,C 2-6炔基,C 3-6环烷基或式-W-Rx的基团,其中W是键,C 2-6亚烯基或 - (CH 2)t - 其中t为1至6; 并且Rx是萘基,呋喃基,噻吩基或苯基,此外Rx可以任选地被一至三个相同或不同的C 1-6烷基,C 1-6烷氧基,卤素或-CF 3基团取代; R3是OCOR,-OCOOR,H或OH; R4是氢; 或R3和R4共同形成羰基; 且R为C 1-6烷基。 本发明还提供了药物制剂(组合物)和用式I化合物治疗哺乳动物肿瘤的方法。

    6,7-modified paclitaxels
    4.
    发明授权
    6,7-modified paclitaxels 失效
    6,7修饰紫杉醇

    公开(公告)号:US5380751A

    公开(公告)日:1995-01-10

    申请号:US128619

    申请日:1993-09-28

    摘要: The present invention provides paclitaxel derivatives of formula I ##STR1## in which R.sup.1 is --COR.sup.z in which R.sup.Z is RO-- or R;R.sup.2 is C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.3-6 cycloalkyl, or a radical of the formula --W--R.sup.x in which W is a bond, C.sub.2-6 alkenediyl, or --(CH.sub.2).sub.t --, in which t is one to six; and R.sup.x is naphthyl, phenyl, or heteroaryl, and furthermore R.sup.x can be optionally substituted with one to three same or different C.sub.1-6 alkyl, C.sub.1-6 alkoxy, halogen or --CF.sub.3 groups;R.sup.a is --OCOR, H, OH, --OR, --OSO.sub.2 R, --OCONR.sup.o R, --OCONHR, --OCOO(CH.sub.2).sub.t R, or --OCOOR;R.sup.b and R.sup.c are both hydroxy or together form a bond with the carbon atoms to which they are attached; andR and R.sup.o are independently C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.3-6 cycloalkyl, C.sub.2-6 alkynyl, or phenyl, optionally substituted with one to three same or different C.sub.1-6 alkyl, C.sub.1-6 alkoxy, halogen or --CF.sub.3 groups.Also provided by this invention are pharmaceutical formulations (compositions) and a method of treating mammalian tumors with a compound of formula I.

    摘要翻译: 本发明提供式I的紫杉醇衍生物,其中R 1是其中R Z是RO-或R的-CORz; R 2是C 1-6烷基,C 2-6烯基,C 2-6炔基,C 3-6环烷基或式-W-Rx的基团,其中W是键,C 2-6亚烯基或 - (CH 2)t - 其中t为1至6; 并且Rx是萘基,苯基或杂芳基,此外Rx可任选地被一至三个相同或不同的C 1-6烷基,C 1-6烷氧基,卤素或-CF 3基团取代; R a是-OCOR,H,OH,-OR,-OSO 2 R,-OCONRoR,-OCONHR,-OCOO(CH 2)t R或-OCOOR; Rb和Rc都是羟基或与它们所连接的碳原子一起形成键; 并且R和R 4独立地是C 1-6烷基,C 2-6烯基,C 3-6环烷基,C 2-6炔基或苯基,任选地被一至三个相同或不同的C 1-6烷基,C 1-6烷氧基,卤素或 -CF3组。 本发明还提供了药物制剂(组合物)和用式I化合物治疗哺乳动物肿瘤的方法。

    Taxol derivatives
    5.
    发明授权
    Taxol derivatives 失效
    紫杉醇衍生物

    公开(公告)号:US5248796A

    公开(公告)日:1993-09-28

    申请号:US900365

    申请日:1992-06-18

    IPC分类号: C07D305/14

    CPC分类号: C07D305/14 C07C2103/80

    摘要: The present invention relates to 10-desacetoxy-11,12-dihydrotaxol-10,12(18)-diene derivatives which are useful as antitumor agents and as intermediates for the preparation of 10-desacetoxytaxol. Also disclosed is a novel process for the preparation of 10-desacetoxytaxol which comprises treating hydroxy protected 10-deacetyltaxol with 1,1,2-trifluoro-2-chlorotriethylamine followed by catalytic hydrogenation.

    摘要翻译: 本发明涉及可用作抗肿瘤剂的10-脱乙酰氧基-11,12-二氢塔考醇-10,12(18) - 二烯衍生物,作为制备10-脱乙酰氧基紫杉醇的中间体。 还公开了一种用于制备10-脱乙酰氧基紫杉醇的新方法,其包括用1,1,2-三氟-2-氯三乙胺处理羟基保护的10-脱乙酰紫杉醇,然后催化氢化。

    Fluoro taxols
    6.
    发明授权

    公开(公告)号:US5192796A

    公开(公告)日:1993-03-09

    申请号:US907261

    申请日:1992-07-01

    摘要: This invention relates to a fluorinated taxol of formula I ##STR1## in which R.sup.1 is benzoyl or t-butyloxycarbonyl; R.sup.2 is acetoxy, hydrogen or hydroxy; and the wavy line indicates either the .alpha.- or the .beta.-configuration.Further provided by this invention are pharmaceutical formulations and useful intermediates for the fluorinated taxols of formula I. A method of treating mammalian tumors using a compound of formula I is also provided.

    Deoxy taxols
    7.
    发明授权
    Deoxy taxols 失效
    脱氧紫杉醇

    公开(公告)号:US5478854A

    公开(公告)日:1995-12-26

    申请号:US212447

    申请日:1994-03-10

    摘要: R.sup.g is C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.3-6 cycloalkyl, or a radical of the formula --W--R.sup.x in which W is a bond, C.sub.2-6 alkenediyl, or --(CH.sub.2).sub.t --, in which t is one to six; and R.sup.x is naphthyl, phenyl, or heteroaryl, and furthermore R.sup.x can be optionally substituted with one to three same or different C.sub.1-6 alkyl, C.sub.1-6 alkoxy, halogen or --CF.sub.3 groups;R.sup.2 is --OCOR, H, OH, --OR, --OSO.sub.2 R, --OCONR.sup.o R, --OCONHR, --OCOO(CH.sub.2).sub.t R, or --OCOOR; andR and R.sup.o are independently C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.3-6 cycloalkyl, C.sub.2-6 alkynyl, or phenyl, optionally substituted with one to three same or different C.sub.1-6 alkyl, C.sub.1-6 alkoxy, halogen or --CF.sub.3 groups.Further provided by this invention are pharmaceutical formulations and intermediates for the the preparation of deoxy taxols of formula I. A method of treating mammalian tumors using a compound of formula I is also provided.

    摘要翻译: 其中R 1是-COR z,其中R z是RO-或R; R 8为C 1-6烷基,C 2-6烯基,C 2-6炔基,C 3-6环烷基或W-Rx基团,W为键,C 2-6亚烯基或 - (CH 2)t - 其中t为1至6; 并且Rx是萘基,苯基或杂芳基,此外Rx可任选地被一至三个相同或不同的C 1-6烷基,C 1-6烷氧基,卤素或-CF 3基团取代; R2是-OCOR,H,OH,-OR,-OSO2R,-OCONRoR,-OCONHR,-OCOO(CH2)tR或-OCOOR; 并且R和R 4独立地是C 1-6烷基,C 2-6烯基,C 3-6环烷基,C 2-6炔基或苯基,任选地被一至三个相同或不同的C 1-6烷基,C 1-6烷氧基,卤素或 -CF3组。 本发明进一步提供了用于制备式I的脱氧紫杉醇的药物制剂和中间体。还提供了使用式I化合物治疗哺乳动物肿瘤的方法。

    Fluoro taxols
    8.
    发明授权
    Fluoro taxols 失效
    氟紫杉醇

    公开(公告)号:US5294637A

    公开(公告)日:1994-03-15

    申请号:US62687

    申请日:1993-05-20

    摘要: This invention relates to a fluorinated taxol of formula I ##STR1## in which R.sup.1 is --COR.sup.z in which R.sup.z is RO-- or R;R.sup.g is C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.3-6 cycloalkyl, or a radical of the formula --W--R.sup.x in which W is a bond, C.sub.2-6 alkenediyl, or --(CH.sub.2).sub.t --, in which t is one to six; and R.sup.x is naphthyl, furyl, thienyl or phenyl, and furthermore R.sup.x can be optionally substituted with one to three same or different C.sub.1-6 alkyl, C.sub.1-6 alkoxy, halogen or --CF.sub.3 groups;R.sup.2 is --OCOR, H, OH, --OR, --OSO.sub.2 R, --OCONR.sup.o R, --OCONHR, --OCOO(CH.sub.2).sub.t R, or --OCOOR; andR and R.sup.o are independently C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.3-6 cycloalkyl, C.sub.2-6 alkynyl, or phenyl, optionally substituted with one to three same or different C.sub.1-6 alkyl, C.sub.1-6 alkoxy, halogen or --CF.sub.3 groups.Further provided by this invention are pharmaceutical formulations and useful intermediates for the fluorinated taxols of formula I. A method of treating mammalian tumors using a compound of formula I is also provided.

    摘要翻译: 本发明涉及式I的氟化紫杉醇,其中R 1是-COR 3,其中R z是RO-或R; R 8为C 1-6烷基,C 2-6烯基,C 2-6炔基,C 3-6环烷基或W-Rx基团,W为键,C 2-6亚烯基或 - (CH 2)t - 其中t为1至6; 并且Rx是萘基,呋喃基,噻吩基或苯基,此外Rx可以任选地被一至三个相同或不同的C 1-6烷基,C 1-6烷氧基,卤素或-CF 3基团取代; R2是-OCOR,H,OH,-OR,-OSO2R,-OCONRoR,-OCONHR,-OCOO(CH2)tR或-OCOOR; 并且R和R 4独立地是C 1-6烷基,C 2-6烯基,C 3-6环烷基,C 2-6炔基或苯基,任选地被一至三个相同或不同的C 1-6烷基,C 1-6烷氧基,卤素或 -CF3组。 本发明进一步提供了用于式I的氟化紫杉醇的药物制剂和有用的中间体。还提供了使用式I化合物治疗哺乳动物肿瘤的方法。

    Process of making substituted pyrazoles
    9.
    发明授权
    Process of making substituted pyrazoles 有权
    制备取代的吡唑的方法

    公开(公告)号:US06407238B1

    公开(公告)日:2002-06-18

    申请号:US09698442

    申请日:2000-10-27

    IPC分类号: C07D40304

    CPC分类号: C07D231/12

    摘要: Disclosed is a process of making substituted pyrazoles from substituted benzophenone hydrazones with a variety of 1,3-bifunctional substrates under acid conditions. The pyrazole compounds are useful for making pharmaceutical compounds.

    摘要翻译: 公开了在酸性条件下由具有各种1,3-双官能底物的取代的二苯甲酮腙制备取代的吡唑的方法。 吡唑化合物可用于制备药物化合物。